# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-023301
Filing Date
2025-02-19
Accepted
2025-02-19 16:55:23
Documents
67
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | mnov-20241231.htm iXBRL | 10-K | 2157348
2 | EX-19.1 | mnov-ex19_1.htm | EX-19.1 | 259839
3 | EX-23.1 | mnov-ex23_1.htm | EX-23.1 | 4437
4 | EX-31.1 | mnov-ex31_1.htm | EX-31.1 | 12542
5 | EX-31.2 | mnov-ex31_2.htm | EX-31.2 | 12467
6 | EX-32.1 | mnov-ex32_1.htm | EX-32.1 | 10161
7 | EX-32.2 | mnov-ex32_2.htm | EX-32.2 | 10511
| Complete submission text file | 0000950170-25-023301.txt |  | 8451958

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mnov-20241231.xsd | EX-101.SCH | 987879
70 | EXTRACTED XBRL INSTANCE DOCUMENT | mnov-20241231_htm.xml | XML | 1416456

Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 25641314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)